TCL Archive Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says September 6, 2002
TCL Archive Watson, Weinstein Decide FCRC Isn’t So Bad After all; DCCP to Develop RFAs, RFPs With Help Of Workshops May 11, 1979
TCL Archive “Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million December 6, 1974
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
